Javascript must be enabled to continue!
Pharmacology of Vigabatrin
View through CrossRef
Abstract: Vigabatrin (gamma‐vinyl GABA) is a relatively new antiepileptic drug. Vigabatrin increases the concentration of gamma‐aminobutyric acid (GABA) in the brain by inhibiting the major GABA metabolizing enzyme, GABA transaminase. Controlled clinical trials have demonstrated an excellent antiepileptic effect of vigabatrin, especially in the treatment of partial epilepsies. Long‐term evaluations have shown no signs of tolerance development. Vigabatrin decreases the plasma concentration of phenytoin during concomitant therapy, the only drug with which an interaction seems to occur. In general, vigabatrin is well tolerated. Psychotic reactions occur in 3–6% of patients. Other frequent side effects are sedation and weight increase. Chronic vigabatrin intoxication in animals caused development of intramyelinic oedema, appearing as microvacuoles in brain white matter. No microvacuolation has been observed in humans, even after long‐term treatment. Vigabatrin seems a very valuable new antiepileptic drug.
Title: Pharmacology of Vigabatrin
Description:
Abstract: Vigabatrin (gamma‐vinyl GABA) is a relatively new antiepileptic drug.
Vigabatrin increases the concentration of gamma‐aminobutyric acid (GABA) in the brain by inhibiting the major GABA metabolizing enzyme, GABA transaminase.
Controlled clinical trials have demonstrated an excellent antiepileptic effect of vigabatrin, especially in the treatment of partial epilepsies.
Long‐term evaluations have shown no signs of tolerance development.
Vigabatrin decreases the plasma concentration of phenytoin during concomitant therapy, the only drug with which an interaction seems to occur.
In general, vigabatrin is well tolerated.
Psychotic reactions occur in 3–6% of patients.
Other frequent side effects are sedation and weight increase.
Chronic vigabatrin intoxication in animals caused development of intramyelinic oedema, appearing as microvacuoles in brain white matter.
No microvacuolation has been observed in humans, even after long‐term treatment.
Vigabatrin seems a very valuable new antiepileptic drug.
Related Results
Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy
Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy
Summary
Purpose:
Vigabatrin used to treat infantile s...
Evidence for both in vivo and in vitro interaction between vigabatrin and alanine transaminase
Evidence for both in vivo and in vitro interaction between vigabatrin and alanine transaminase
Aims Decreases in plasma alanine transaminase (ALA‐T) activity of 20–100% have been reported following the use of vigabatrin (Sabril) in patients with uncontrolled epilepsy. This e...
Infantile Spasms and Epilepsy Currents
Infantile Spasms and Epilepsy Currents
The United Kingdom Infantile Spasms Study Comparing Vigabatrin with Prednisolone or Tetracosactide at 14 Days: A Multicentre, Randomised Controlled Trial Lux AL, Edwards SW, Hanco...
Vigabatrin versus ACTH in the treatment of infantile spasms
Vigabatrin versus ACTH in the treatment of infantile spasms
OBJECTIVE: To compare adrenocorticotropic hormone with vigabatrin as a single mono-therapy for infantile spasms. We studied hospitalization time, clinical response, whether complet...
Vigabatrin: Lessons Learned From the United States Experience
Vigabatrin: Lessons Learned From the United States Experience
Abstract:
Vigabatrin was introduced as an antiseizure medication in the United Kingdom in 1989 and was extensively used until 1997 when concerns arose regarding periphera...
Clinical pharmacology of vigabatrin.
Clinical pharmacology of vigabatrin.
1. Upon oral administration vigabatrin is rapidly absorbed. Plasma elimination half‐life ranges between 5 and 7 h in normal volunteers. Vigabatrin is eliminated primarily via the k...
A Comparative Study of An Updated Pharmacology and Therapeutics Curriculum for MBBS in Bangladesh with Previous Curriculum
A Comparative Study of An Updated Pharmacology and Therapeutics Curriculum for MBBS in Bangladesh with Previous Curriculum
Background: There have been several revisions of the medical curriculum of Bangladesh. Presently we are teaching students under two curriculum, 2012 and 2021 curriculum in Pharmaco...
A concise review on analytical profile of Vigabatrin
A concise review on analytical profile of Vigabatrin
Vigabatrin (VGB) is a drug of Anticonvulsant class. It works by decreasing abnormal electrical activity in the brain. It inhibits the GABA-degrading enzyme i.e. GABA transaminase, ...

